期刊文献+

γ-氨基丁酸B型受体在恶性肿瘤中的研究进展

Research Progress of Gamma-aminobutyric Acid B Receptor in Malignant Tumors
下载PDF
导出
摘要 γ-氨基丁酸(GABA)是中枢神经系统中一种重要的抑制性神经递质,对神经元的兴奋程度有重要影响,也是大脑能量代谢过程中重要的氨基酸。其常用于抗惊厥、抗焦虑和治疗癫痫。近年来,在很多肿瘤细胞中发现γ-氨基丁酸B型受体(GABA_(B)R),其与GABA结合后呈现出完全不同的作用。肿瘤细胞可能通过GABA信号调节其新陈代谢和分裂增殖,同时这些信号也可能影响免疫细胞的功能,进而影响肿瘤微环境。因此,深入研究不同肿瘤中GABA_(B)R的表达情况以及功能,有助于了解其与免疫治疗的关系,开发相应的抗肿瘤药物,提供新的抗肿瘤策略。 Gamma-aminobutyric acid(GABA)is a crucial inhibitory neurotransmitter within the central nervous system,with significant influence on neuronal excitability and serving as an important amino acid in the brain′s energy metabolism.It is commonly used for anticonvulsion,anti-anxiety,and treatment of epilepsy.In recent years,it has been found in many tumor cells that GABA B receptor(GABA_(B)R)exhibits completely different effects when bound to GABA.Tumor cells may regulate their metabolism and proliferation through GABA signaling,and these signals may also affect the function of immune cells,thereby affecting the tumor microenvironment.Therefore,in-depth research on the expression and function of GABA_(B)R in different tumors can help understand its relationship with immunotherapy,develop corresponding anti-tumor drugs,and provide new anti-tumor strategies.
作者 陈南廷 廖凡勋 杨博翔 王威巍 CHEN Nanting;LIAO Fanxun;YANG Boxiang;WANG Weiwei(The Second Clinical College of Chongqing Medical University,Chongqing 400016,China;Department of Hepatopancreatobiliary Surgery,Chongqing City Tongliang District People′s Hospital,Chongqing 402560,China;Department of Infection,Pingchang People′s Hospital,Pingchang 636499,China)
出处 《医学综述》 CAS 2024年第11期1303-1308,共6页 Medical Recapitulate
基金 重庆市铜梁区基础研究与前沿探索专项(2023002)。
关键词 恶性肿瘤 Γ-氨基丁酸 γ-氨基丁酸B型受体 Malignant tumors Gamma-aminobutyric acid Gamma-aminobutyric acid B receptor
  • 相关文献

参考文献3

二级参考文献25

  • 1秦苏堤,朱人敏,何小平,汪芳裕.γ-氨酪酸和谷氨酸与胃癌关系的研究[J].医学研究生学报,2004,17(7):620-623. 被引量:3
  • 2[1]Tatsuta M, Iishi H, Baba M et al. Inhibition by gamma-amino-n-butyric acid and baclofen of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Cancer Res, 1990,50(16):4931
  • 3[2]Billinton A. Advances in the molecular understanding of GABAB receptors. Trends Neurosci, 2001,24:277
  • 4[3]Matuszek M, Jesipowicz M, Kleinrok Z. GABA content and GAD activity in gastric cancer. Med Sci Monit, 2001,7(3):377
  • 5[5]Bormann J. The ‘ABC' of GABA receptors. Trends Pharmacol Sci, 2000,21:16
  • 6[6]Martin SC, Russek SJ, Farb DH. Molecular identification of the human GABABR2: cell surface expression and coupling to adenylyl cyclase in the absence of GABABR1. Mol Cell Neurosci, 1999,13(3):180
  • 7[7]Charles KJ, Evans ML, Robbins MJ et al. Comparative immunohistochemical localization of GABAB1a, GABAB1b and GABAB2 subunits in rat brain, spinal cord and dorsal root ganglion. Neuroscience, 2001,106(3):447
  • 8[8]Misgeld Ul, Bijak M, Jarolimek W. A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system. Prog Neurobiol, 1995,46(4):423
  • 9[9]Ige AO, Bolam JP, Billinton A et al. Cellular and sub-cellular localisation of GABAB1 and GABAB2 receptor proteins in the rat cerebellum. Mol Brain Res, 2000,83(1-2):72
  • 10[10]Martin SC, Russek SJ, Farb DH. Human GABABR genomic structure: evidence for splice variants in GABABR1 but not GABABR2. Gene, 2001,278(1-2):63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部